Therefore, AR may play biphasic roles in different stages of neuroendocrine differentiation in prostate cancer, and the molecular characteristic of AR during the progression of neuroendocrine differentiation would potentially guide the clinical therapeutic strategy and future investigations. This evidence concerns the gene AR and prostate carcinoma.